241 related articles for article (PubMed ID: 20339138)
1. Arsenic-specific stem cell selection during malignant transformation.
Tokar EJ; Qu W; Liu J; Liu W; Webber MM; Phang JM; Waalkes MP
J Natl Cancer Inst; 2010 May; 102(9):638-49. PubMed ID: 20339138
[TBL] [Abstract][Full Text] [Related]
2. Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype.
Tokar EJ; Diwan BA; Waalkes MP
Environ Health Perspect; 2010 Jan; 118(1):108-15. PubMed ID: 20056578
[TBL] [Abstract][Full Text] [Related]
3. Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic.
Ngalame NN; Tokar EJ; Person RJ; Xu Y; Waalkes MP
Toxicol Sci; 2014 Apr; 138(2):268-77. PubMed ID: 24431212
[TBL] [Abstract][Full Text] [Related]
4. Silencing KRAS overexpression in arsenic-transformed prostate epithelial and stem cells partially mitigates malignant phenotype.
Ngalame NN; Tokar EJ; Person RJ; Waalkes MP
Toxicol Sci; 2014 Dec; 142(2):489-96. PubMed ID: 25273566
[TBL] [Abstract][Full Text] [Related]
5. Requirement of arsenic biomethylation for oxidative DNA damage.
Kojima C; Ramirez DC; Tokar EJ; Himeno S; Drobná Z; Stýblo M; Mason RP; Waalkes MP
J Natl Cancer Inst; 2009 Dec; 101(24):1670-81. PubMed ID: 19933942
[TBL] [Abstract][Full Text] [Related]
6. Arsenic-transformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype.
Xu Y; Tokar EJ; Sun Y; Waalkes MP
Environ Health Perspect; 2012 Jun; 120(6):865-71. PubMed ID: 22472196
[TBL] [Abstract][Full Text] [Related]
7. Aberrant cytokeratin expression during arsenic-induced acquired malignant phenotype in human HaCaT keratinocytes consistent with epidermal carcinogenesis.
Sun Y; Pi J; Wang X; Tokar EJ; Liu J; Waalkes MP
Toxicology; 2009 Aug; 262(2):162-70. PubMed ID: 19524636
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of normal stem cells to an oncogenic phenotype by noncontiguous carcinogen-transformed epithelia depends on the transforming carcinogen.
Xu Y; Tokar EJ; Person RJ; Orihuela RG; Ngalame NN; Waalkes MP
Environ Health Perspect; 2013 Aug; 121(8):944-50. PubMed ID: 23687063
[TBL] [Abstract][Full Text] [Related]
9. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation.
Benbrahim-Tallaa L; Waterland RA; Styblo M; Achanzar WE; Webber MM; Waalkes MP
Toxicol Appl Pharmacol; 2005 Aug; 206(3):288-98. PubMed ID: 16039940
[TBL] [Abstract][Full Text] [Related]
10. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
11. EMT and CSC-like properties mediated by the IKKβ/IκBα/RelA signal pathway via the transcriptional regulator, Snail, are involved in the arsenite-induced neoplastic transformation of human keratinocytes.
Jiang R; Li Y; Xu Y; Zhou Y; Pang Y; Shen L; Zhao Y; Zhang J; Zhou J; Wang X; Liu Q
Arch Toxicol; 2013 Jun; 87(6):991-1000. PubMed ID: 23069812
[TBL] [Abstract][Full Text] [Related]
12. Overabundance of putative cancer stem cells in human skin keratinocyte cells malignantly transformed by arsenic.
Sun Y; Tokar EJ; Waalkes MP
Toxicol Sci; 2012 Jan; 125(1):20-9. PubMed ID: 22011395
[TBL] [Abstract][Full Text] [Related]
13. Inorganic arsenite-induced malignant transformation of human prostate epithelial cells.
Achanzar WE; Brambila EM; Diwan BA; Webber MM; Waalkes MP
J Natl Cancer Inst; 2002 Dec; 94(24):1888-91. PubMed ID: 12488483
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 and epidermal growth factor promote anchorage-independent growth of immortalized human prostatic epithelial cells treated with N-methyl-N-nitrosourea.
Okamoto M; Webber MM; Quader S; Oyasu R
Prostate; 1998 Jun; 35(4):255-62. PubMed ID: 9609548
[TBL] [Abstract][Full Text] [Related]
15. Chronic arsenic-exposed human prostate epithelial cells exhibit stable arsenic tolerance: mechanistic implications of altered cellular glutathione and glutathione S-transferase.
Brambila EM; Achanzar WE; Qu W; Webber MM; Waalkes MP
Toxicol Appl Pharmacol; 2002 Sep; 183(2):99-107. PubMed ID: 12387749
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-155 regulates arsenite-induced malignant transformation by targeting Nrf2-mediated oxidative damage in human bronchial epithelial cells.
Chen C; Jiang X; Gu S; Zhang Z
Toxicol Lett; 2017 Aug; 278():38-47. PubMed ID: 28688901
[TBL] [Abstract][Full Text] [Related]
17. Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.
Ngalame NN; Makia NL; Waalkes MP; Tokar EJ
Toxicol Appl Pharmacol; 2016 Dec; 312():11-18. PubMed ID: 26721309
[TBL] [Abstract][Full Text] [Related]
18. Human prostate epithelial cells and prostate-derived stem cells malignantly transformed in vitro with sodium arsenite show impaired Toll like receptor -3 (TLR3)-associated anti-tumor pathway.
Alvarado-Morales I; Olivares-Illana V; Arenas-Huertero C; Reynaga-Hernández E; Layseca-Espinosa E; Tokar EJ; Escudero-Lourdes C
Toxicol Lett; 2021 Oct; 350():185-193. PubMed ID: 34303791
[TBL] [Abstract][Full Text] [Related]
19. EMT and stem cell-like properties associated with HIF-2α are involved in arsenite-induced transformation of human bronchial epithelial cells.
Xu Y; Li Y; Pang Y; Ling M; Shen L; Yang X; Zhang J; Zhou J; Wang X; Liu Q
PLoS One; 2012; 7(5):e37765. PubMed ID: 22662215
[TBL] [Abstract][Full Text] [Related]
20. Further studies on aberrant gene expression associated with arsenic-induced malignant transformation in rat liver TRL1215 cells.
Liu J; Benbrahim-Tallaa L; Qian X; Yu L; Xie Y; Boos J; Qu W; Waalkes MP
Toxicol Appl Pharmacol; 2006 Nov; 216(3):407-15. PubMed ID: 16876216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
